XML 59 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity (Tables)
12 Months Ended
Jun. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Dividends declared and paid

Fiscal Year

    

2024

    

2023

Fourth quarter ended June 30,

$

0.12

$

0.12

Third quarter ended March 31,

0.12

0.12

Second quarter ended December 31,

0.12

0.12

First quarter ended September 30,

0.12

0.12

Schedule of share repurchases

Years Ended June 30, 

    

2024

2023

Number of treasury shares acquired(1)

202

673

Average cost per share(1)

$

5.66

$

6.20

Total cost of treasury shares acquired

$

1,144

$

4,170

(1)For the year ended June 30, 2024, includes 140,672 shares repurchased under the Company’s share repurchase program for a weighted average price of $5.33 per share. For the year ended June 30, 2023, includes 633,789 shares repurchased under the Company’s share repurchase program for a weighted average price of $6.07 per share.
Schedule of Market-based Award Valuation Assumptions

Years Ended June 30, 

    

2024

    

2023

Weighted average fair value of performance-based awards granted

$

3.58

$

6.52

Risk-free interest rate

4.87%

3.91% to 4.51%

Expected term in years

2.77

2.36 to 2.78

Expected volatility

55.0%

56.5% to 70.9%

Dividend yield

7.4%

6.1% to 7.8%

Schedule of restricted stock transactions

Weighted

Number of

Average

Restricted

Grant-Date

Award Type

    

Shares

    

Fair Value

Time-vested awards

395,104

$

6.57

Performance-based awards

233,407

5.87

Unvested at June 30, 2024

628,511

$

6.31

Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock transactions

The following table sets forth the restricted stock award transactions for the years ended June 30, 2024 and 2023:

Weighted

Weighted

Unamortized

Average

Number of

Average

Compensation

Remaining

Aggregate Intrinsic

Restricted

Grant-Date

Expense

Amortization

Value (1)

    

Shares

    

Fair Value

    

(In thousands)

    

Period (Years)

    

(In thousands)

Unvested at June 30, 2022

341,211

$

4.54

Time-vested shares granted

376,015

7.18

Performance-based shares granted

100,239

7.39

Vested

(196,431)

4.91

Forfeited

(25,620)

6.51

Unvested at June 30, 2023

595,414

$

6.48

$

2,827

2.4

$

4,805

Time-vested shares granted

157,692

6.22

Performance-based shares granted

136,315

4.80

Vested

(260,910)

5.85

Unvested at June 30, 2024

628,511

$

6.31

$

2,492

1.8

$

3,312

(1)The intrinsic value of restricted stock was calculated as the closing market price on June 30, 2024 and 2023 of the underlying stock multiplied by the number of restricted shares that would be issuable. The total fair value of shares vested was $1.6 million and $1.4 million for the years ended June 30, 2024 and 2023, respectively.
Contingent restricted stock grants  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted stock transactions

The following table sets forth contingent restricted stock unit transactions for the years ended June 30, 2024 and 2023:

Weighted

Unamortized

Average

Number of

Weighted Average

Compensation

Remaining

Aggregate Intrinsic

Restricted

Grant-Date

Expense

Amortization

Value (1)

 

    

Stock Units

    

Fair Value

    

(In thousands)

    

Period (Years)

    

(In thousands)

Unvested at June 30, 2022

50,062

$

2.21

Performance-based awards granted

50,123

4.79

Forfeited

(3,787)

3.69

Unvested at June 30, 2023

96,398

$

3.49

$

195

1.9

$

778

Performance-based awards granted

102,239

1.95

Expired

(47,849)

2.19

Unvested at June 30, 2024

150,788

$

2.86

$

230

1.6

$

795

(1)The intrinsic value of contingent restricted stock units was calculated as the closing market price on June 30, 2024 and 2023 of the underlying stock multiplied by the number of restricted shares that would be issuable.